Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease
Author(s) -
Takahiro Fujimaki,
Shinji Saiki,
Etsu Tashiro,
Daisuke Yamada,
Mitsuhiro Kitagawa,
Nobutaka Hattori,
Masaya Imoto
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0100395
Subject(s) - neuroprotection , programmed cell death , reactive oxygen species , glycyrrhiza , pharmacology , mitochondrion , biology , apoptosis , traditional medicine , medicine , microbiology and biotechnology , chemistry , biochemistry , pathology , alternative medicine
In the course of screening for the anti-Parkinsonian drugs from a library of traditional herbal medicines, we found that the extracts of choi-joki-to and daio-kanzo-to protected cells from MPP + -induced cell death. Because choi-joki-to and daio-kanzo-to commonly contain the genus Glycyrrhiza , we isolated licopyranocoumarin (LPC) and glycyrurol (GCR) as potent neuroprotective principals from Glycyrrhiza . LPC and GCR markedly blocked MPP + -induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK. LPC and GCR inhibited MPP + -induced JNK activation through the suppression of reactive oxygen species (ROS) generation, thereby inhibiting MPP + -induced neuronal PC12D cell death. These results indicated that LPC and GCR derived from choi-joki-to and daio-kanzo-to would be promising drug leads for PD treatment in the future.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom